Hirotaka Ieki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Left Atrial Appendage

Percutaneous Coronary Intervention

Oral Anticoagulants

Top Venues

Nature genetics

Communications medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Kazuo Miyazawa, Shefali S Verma, Masamichi Ito, Zhaonan Zou, Masayuki Kubota, Seitaro Nomura, Hiroshi Matsunaga, Satoshi Koyama, Hirotaka Ieki, Masato Akiyama, Yoshinao Koike, Ryo Kurosawa, Hiroki Yoshida, Kouichi Ozaki, Yoshihiro Onouchi, null null, Atsushi Takahashi, Koichi Matsuda, Yoshinori Murakami, Hiroyuki Aburatani, Michiaki Kubo, Yukihide Momozawa, Chikashi C Terao, Shinya Oki, Hiroshi Akazawa, Yoichiro Kamatani, Issei Komuro
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nature genetics 55 (2) (2023)
Hirotaka Ieki, Shefali S Verma, Mike Saji, Rei Kawakami, Yuji Nagatomo, Kaori Takada, Toshiya Kariyasu, Haruhiko Machida, Satoshi Koyama, Hiroki Yoshida, Ryo Kurosawa, Hiroshi Matsunaga, Kazuo Miyazawa, Kouichi Ozaki, Yoshihiro Onouchi, Susumu Katsushika, Ryo Matsuoka, Hiroki Shinohara, Toshihiro Yamaguchi, Satoshi Kodera, Yasutomi Higashikuni, Katsuhito Fujiu, Hiroshi Akazawa, Nobuo Iguchi, Mitsuaki Isobe, Tsutomu Yoshikawa, Issei Komuro
Deep learning-based age estimation from chest X-rays indicates cardiovascular prognosis. Communications medicine 2 (1) (2022)
Hirotaka Ieki, Shefali S Verma, Mike Saji, Rei Kawakami, Yuji Nagatomo, Kaori Takada, Toshiya Kariyasu, Haruhiko Machida, Satoshi Koyama, Hiroki Yoshida, Ryo Kurosawa, Hiroshi Matsunaga, Kazuo Miyazawa, Kouichi Ozaki, Yoshihiro Onouchi, Susumu Katsushika, Ryo Matsuoka, Hiroki Shinohara, Toshihiro Yamaguchi, Satoshi Kodera, Yasutomi Higashikuni, Katsuhito Fujiu, Hiroshi Akazawa, Nobuo Iguchi, Mitsuaki Isobe, Tsutomu Yoshikawa, Issei Komuro
Deep learning-based age estimation from chest X-rays indicates cardiovascular prognosis. Communications medicine 2 (1) (2022)
Hirotaka Ieki, Shefali S Verma, Mike Saji, Rei Kawakami, Yuji Nagatomo, Kaori Takada, Toshiya Kariyasu, Haruhiko Machida, Satoshi Koyama, Hiroki Yoshida, Ryo Kurosawa, Hiroshi Matsunaga, Kazuo Miyazawa, Kouichi Ozaki, Yoshihiro Onouchi, Susumu Katsushika, Ryo Matsuoka, Hiroki Shinohara, Toshihiro Yamaguchi, Satoshi Kodera, Yasutomi Higashikuni, Katsuhito Fujiu, Hiroshi Akazawa, Nobuo Iguchi, Mitsuaki Isobe, Tsutomu Yoshikawa, Issei Komuro
Deep learning-based age estimation from chest X-rays indicates cardiovascular prognosis. Communications medicine 2 (1) (2022)